About OKYO OKYO Pharma Limited (NASDAQ: OKYO) is a clinical stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain and dry eye disease, with ...
OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to treat neuropathic corneal pain (NCP), an ocular condition associated with ...
Describes the nature of a clinical study. Types include: Observational study — observes people and measures outcomes without affecting results. Interventional study (clinical trial) — studies new ...
Zacks Small Cap Research on MSN
DWTX: Interim Readout for Halneuron® Phase 2b Trial in CINP in 4Q25…
DWTX READ THE FULL DWTX RESEARCH REPORT Business Update 100 Patients Enrolled in Phase 2b Trial of Halneuron®; Interim Analysis in 4Q25 Dogwood Therapeutics, Inc. (NASDAQ:DWTX) is currently conducting ...
Abstract: Clinical trials previously demonstrated the notable capacity to elicit visual percepts in individuals with visual impairments caused by retinal diseases by electrically stimulating the ...
For the freshest news, join The Borneo Post's Telegram Channel and The Borneo Post on Newswav.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback